What are the normal fetal biometry values (biparietal diameter, head circumference, abdominal circumference, femur length, estimated fetal weight) and uterine fundal height at 29 weeks gestation in a normally growing singleton?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Fetal Parameters at 29 Weeks Gestation

At 29 weeks gestation, normal fetal biometry includes a biparietal diameter of approximately 73-77 mm, head circumference of 265-275 mm, abdominal circumference of 240-260 mm, femur length of 54-58 mm, and estimated fetal weight of 1200-1400 grams, with fundal height measuring approximately 27-31 cm (within 3 cm of gestational age in weeks). 1, 2, 3

Fetal Biometric Measurements

Head Parameters

  • Biparietal diameter (BPD): The outer-inner measurement at 29 weeks typically ranges from 73-77 mm, representing approximately the 10th to 90th percentile for gestational age 3, 4.
  • Head circumference (HC): Normal values at 29 weeks range from 265-275 mm, with HC being a more reliable parameter than BPD when skull shape variations exist 3, 5.

Body Parameters

  • Abdominal circumference (AC): At 29 weeks, AC typically measures 240-260 mm and is the single most useful dimension to evaluate fetal growth 3, 5.
  • Femur length (FL): Normal femur length at 29 weeks ranges from 54-58 mm, serving as the best parameter for evaluating skeletal development 3, 5.

Estimated Fetal Weight

  • EFW at 29 weeks: Normal estimated fetal weight ranges from approximately 1200-1400 grams (10th to 90th percentile), calculated using regression equations combining BPD, HC, AC, and FL 6, 2, 3.
  • Weight estimation accuracy: Formulas based on 3-4 fetal biometric indices are significantly more accurate than those using 1-2 indices for birthweights in the 1000-4500 g range 6.

Fundal Height Assessment

Normal Fundal Height Range

  • Expected measurement: At 29 weeks, fundal height should measure approximately 27-31 cm (within 3 cm of gestational age in weeks using the McDonald rule) 1.
  • Clinical significance: A fundal height measurement ≥3 cm below gestational age (i.e., <26 cm at 29 weeks) requires immediate ultrasound evaluation for suspected fetal growth restriction 1.

Limitations of Fundal Height

  • Reliability factors: Fundal height measurements are less reliable in women with obesity, fibroid uterus, multiple gestations, or non-longitudinal fetal lie 1, 7.
  • Growth monitoring: A change in fundal height of ≤5 mm over a 14-day interval indicates static or slow growth and warrants ultrasound assessment 1.

Growth Assessment Considerations

Definition of Normal Growth

  • Size thresholds: Fetal growth restriction is defined as EFW or AC below the 10th percentile for gestational age, while severe FGR is defined as EFW below the 3rd percentile 6, 1, 2.
  • Population-based standards: The American College of Obstetricians and Gynecologists recommends using population-based growth references (such as Hadlock curves) rather than customized standards for accurate diagnosis 1, 2.

Early vs. Late-Onset Growth Issues

  • 29 weeks classification: At 29 weeks gestation, any diagnosed growth restriction would be classified as early-onset FGR (diagnosed before 32 weeks), which is typically more severe and associated with placental dysfunction 6.
  • Associated risks: Early-onset FGR at this gestational age has higher rates of chromosomal abnormalities (up to 20%) and congenital malformations, requiring detailed anatomic survey 1, 2.

Clinical Surveillance at 29 Weeks

High-Risk Pregnancy Monitoring

  • Doppler assessment timing: For high-risk pregnancies with maternal hypertension, prior FGR, or antiphospholipid syndrome, umbilical artery Doppler surveillance should be initiated at 26-28 weeks and continued through delivery 1, 7.
  • Surveillance frequency: When FGR is diagnosed at 29 weeks with normal Doppler, weekly umbilical artery Doppler and weekly non-stress testing are recommended 1, 2.

Amniotic Fluid Assessment

  • Normal parameters: Amniotic fluid index should be ≥5 cm or maximum vertical pocket ≥2 cm at 29 weeks 6, 1.
  • Clinical significance: Oligohydramnios (AFI <5 cm or MVP <2 cm) at this gestational age reflects chronic placental insufficiency and raises suspicion for FGR 1.

Common Pitfalls to Avoid

Measurement Accuracy

  • Quality assurance: Implementation of quality-assurance programs for ultrasound measurements is essential to maintain accuracy, with averaging of multiple measurements improving reliability 6, 2.
  • Dating prerequisite: Accurate pregnancy dating using first-trimester crown-rump length is essential before interpreting 29-week biometry, as gestational age errors will lead to misclassification of growth status 6, 2, 3.

Clinical Decision-Making

  • Multiple parameters: Measurement of multiple fetal parameters (BPD, HC, AC, FL) provides better assessment than relying on a single measurement, as errors in the same direction across all parameters are unlikely 8, 5.
  • Doppler integration: Do not delay umbilical artery Doppler assessment if FGR is suspected at 29 weeks, as Doppler is essential for distinguishing pathological restriction from constitutional smallness 1, 7.

References

Guideline

Guidelines for Detection and Management of Fetal Growth Restriction (FGR)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guidelines for Assessing and Managing Estimated Fetal Weight (EFW)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

ISUOG Practice Guidelines: ultrasound assessment of fetal biometry and growth.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2019

Research

Fetal biometry: clinical, pathological, and technical considerations.

Obstetrical & gynecological survey, 2001

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Optimal Timing for Fetal Doppler Ultrasound in High-Risk Pregnancies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Ultrasound estimation of gestational age.

Clinical obstetrics and gynecology, 1984

Related Questions

What are the management recommendations for a pregnancy with normal fetal measurements at 12 weeks and no maternal weight gain?
Are additional imaging studies done after the 20-week anatomy scan during pregnancy?
What are the recommendations for a pregnant patient at 6 weeks 5 days gestation with a crown-rump length (CRL) of 0.48cm, fetal heart rate (FHR) of 111 beats per minute, yolk sac (YS) measuring 0.50cm, and gestational sac measuring 0.98cm, indicating a potential discrepancy in gestational age and fetal size?
What is the most effective method for calculating fetal growth?
What is the best next step in managing a 14-week dichorionic diamniotic twin pregnancy?
Will bleeding following a miscarriage eventually stop?
What is the recommended basal‑bolus insulin regimen using Tresiba (insulin degludec) and Novolog (insulin aspart) for a diabetic patient, including starting doses, titration schedule, and administration instructions?
In an adult patient with a hypertensive emergency (systolic ≥180 mm Hg or diastolic ≥120 mm Hg) and no specific organ involvement, what are the target blood pressure goals and the recommended initial intravenous antihypertensive agents with their dosing and titration?
In a 28-year-old woman with a painful 2 × 3 cm fluctuating breast lump that is anechoic on ultrasound with a hypervascular wall and no septations, what is the most appropriate management?
What diseases are associated with positive anti‑SSA (Ro) and anti‑SSB (La) antibodies?
How does amlodipine affect migraine?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.